A 20-months Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium to Evaluate National Vaccination Strategy
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The investigators will conduct a prospective observational study of non-invasive S. pneumoniae infections in Belgium and characterize serotype distributions to evaluate national vaccination programs.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients living in Belgium at the time of the study,
• from whom unduplicated S. pneumoniae isolates were collected in routine practices,
• from non-invasive upper (e.g.: pus/fluid from nasal sinus or from otitis media fluid) or lower respiratory tract (e.g. sputum bronchial or endotracheal aspirate, bronchoalveolar fluid (BAL),…) clinical samples,
• from patients diagnosed with pneumonia, sinusitis and otitis.
Locations
Other Locations
Belgium
Sciensano
RECRUITING
Brussels
Contact Information
Primary
Pieter-Jan Ceyssens, PhD
pieter-jan.ceyssens@sciensano.be
02 373 31 19
Backup
Ioannis Passaris, PhD
ioannis.passaris@sciensano.be
02 373 33 23
Time Frame
Start Date: 2020-09-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 3600
Related Therapeutic Areas
Sponsors
Collaborators: Merck Sharp & Dohme LLC, Pfizer, Universitaire Ziekenhuizen KU Leuven
Leads: Sciensano